PELLICANO, Rinaldo
PELLICANO, Rinaldo
Dip. MEDICINA INTERNA (attivo dal 01/01/1900 al 30/04/2013)
2013 update on celiac disease and eosinophilic esophagitis
2013-01-01 Pellicano, Rinaldo; De Angelis, Claudio; Ribaldone, Davide Giuseppe; Fagoonee, Sharmila; Astegiano, Marco
A 2016 panorama of Helicobacter pylori infection: key messages for clinicians
2016-01-01 Pellicano, Rinaldo; Ribaldone, Davide G; Fagoonee, Sharmila; Astegiano, Marco; Saracco, Giorgio M; Mégraud, Francis
A Concise History of Thiopurines for Inflammatory Bowel Disease: From Anecdotal Reporting to Treat-to-Target Algorithms
2019-01-01 Actis, Giovanni Clemente; Pellicano, Rinaldo; Ribaldone, Davide Giuseppe
A dive into the stem cells world
2009-01-01 Fagoonee S; Pellicano R; Altruda F
A question about dyspeptic patients analyzed using psychometric scores
2018-01-01 Pellicano, Rinaldo; Durazzo, Marilena
A question on Helicobacter pylori prevalence in obese Turkish patients
2018-01-01 Pellicano, R.*; Durazzo, M.
A randomized, double-blind, placebo-controlled pilot study to evaluate the efficacy and tolerability of a novel oral bioadhesive formulation for the treatment of nonerosive reflux disease-related symptoms
2021-01-01 Ribaldone, Davide Giuseppe; Rajesh, Pendlimari; Chandradhara, Divya; Astegiano, Marco; Pellicano, Rinaldo
A Retrospective Experience of Helicobacter pylori Histology in a Large Sample of Subjects in Northern Italy
2021-01-01 Ribaldone, DG; Zurlo, C; Fagoonee, S; Rosso, C; Armandi, A; Caviglia, GP; Saracco, GM; Pellicano, R
Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn's Disease
2019-01-01 Ribaldone, Davide Giuseppe; Caviglia, Gian Paolo; Abdulle, Amina; Pellicano, Rinaldo; Ditto, Maria Chiara; Morino, Mario; Fusaro, Enrico; Saracco, Giorgio Maria; Bugianesi, Elisabetta; Astegiano, Marco
Adalimumab trough levels predict Crohn's disease clinical course
2018-01-01 Ribaldone, Davide Giuseppe*; Manetta, Tilde; Mengozzi, Giulio; Saracco, Giorgio Maria; Pellicano, Rinaldo; Astegiano, Marco
Adalimumab versus azathioprine to halt the progression of bowel damage in Crohn’s disease: application of Lémann Index
2019-01-01 Ribaldone D.G.; Caviglia G.P.; Pellicano R.; Vernero M.; Italia A.; Morino M.; Saracco G.M.; Astegiano M.
Alpha1-antitrypsin deficiency: What's new after European Respiratory Society Statement
2018-01-01 Patrucco F.; Venezia L.; Gavelli F.; Pellicano R.; Solidoro P.
AMOXYCILLIN AND METRONIDAZOLE THERAPY FOR HELICOBACTER PYLORI ERADICATION: A 10-YEAR TREND IN TURIN, ITALY
2017-01-01 Ribaldone, davide giuseppe; Astegiano, Marco; Saracco, Giorgio; Pellicano, Rinaldo
Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory bowel disease
2008-01-01 Simondi D.; Mengozzi G.; Betteto S.; Bonardi R.; Ghignone R.P.; Fagoonee S.; Pellicano R.; Sguazzini C.; Pagni R.; Rizzetto M.; Astegiano M.
Apparent diffusion coefficient and enhancement patterns in MR imaging as markers of severe or moderate ileum inflammation in Crohn's disease
2019-01-01 Faletti, R; Ribaldone, DG; Gatti, M; Perazzini, C; Robella, M; Angelino, F; Saracco, GM; Astegiano, M; Pellicano, R; Fonio, P
Asthma and gastroesophageal reflux disease: A multidisciplinary point of view
2017-01-01 Solidoro P.; Patrucco F.; Fagoonee S.; Pellicano R.
Autoimmune Hepatitis and Fibrosis
2023-01-01 Pellicano, Rinaldo; Ferro, Arianna; Cicerchia, Francesca; Mattivi, Simone; Fagoonee, Sharmila; Durazzo, Marilena
Bariatric Surgery and Inflammatory Bowel Disease: a Role for Microbiota?
2020-01-01 Ribaldone D.G.; Pellicano R.
Benefit of supplements in functional dyspepsia after treatment of Helicobacter pylori
2014-01-01 Pellicano, R; Ribaldone, D.G.; Saracco, G.M.; Leone, N.; De Angelis, C.; Arrigoni, A.; Morello, E.; Sapone, N.; Cisarò, F.; Astegiano, M.
Causes of childhood epilepsy: a look for celiac disease?
2021-01-01 RIBALDONE, Davide G.; PELLICANO, Rinaldo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 2013 update on celiac disease and eosinophilic esophagitis | 2013 | Pellicano, Rinaldo; De Angelis, Claudio; Ribaldone, Davide Giuseppe; Fagoonee, Sharmila; Astegiano, Marco | |
| A 2016 panorama of Helicobacter pylori infection: key messages for clinicians | 2016 | Pellicano, Rinaldo; Ribaldone, Davide G; Fagoonee, Sharmila; Astegiano, Marco; Saracco, Giorgio M; Mégraud, Francis | |
| A Concise History of Thiopurines for Inflammatory Bowel Disease: From Anecdotal Reporting to Treat-to-Target Algorithms | 2019 | Actis, Giovanni Clemente; Pellicano, Rinaldo; Ribaldone, Davide Giuseppe | |
| A dive into the stem cells world | 2009 | Fagoonee S; Pellicano R; Altruda F | |
| A question about dyspeptic patients analyzed using psychometric scores | 2018 | Pellicano, Rinaldo; Durazzo, Marilena | |
| A question on Helicobacter pylori prevalence in obese Turkish patients | 2018 | Pellicano, R.*; Durazzo, M. | |
| A randomized, double-blind, placebo-controlled pilot study to evaluate the efficacy and tolerability of a novel oral bioadhesive formulation for the treatment of nonerosive reflux disease-related symptoms | 2021 | Ribaldone, Davide Giuseppe; Rajesh, Pendlimari; Chandradhara, Divya; Astegiano, Marco; Pellicano, Rinaldo | |
| A Retrospective Experience of Helicobacter pylori Histology in a Large Sample of Subjects in Northern Italy | 2021 | Ribaldone, DG; Zurlo, C; Fagoonee, S; Rosso, C; Armandi, A; Caviglia, GP; Saracco, GM; Pellicano, R | |
| Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn's Disease | 2019 | Ribaldone, Davide Giuseppe; Caviglia, Gian Paolo; Abdulle, Amina; Pellicano, Rinaldo; Ditto, Maria Chiara; Morino, Mario; Fusaro, Enrico; Saracco, Giorgio Maria; Bugianesi, Elisabetta; Astegiano, Marco | |
| Adalimumab trough levels predict Crohn's disease clinical course | 2018 | Ribaldone, Davide Giuseppe*; Manetta, Tilde; Mengozzi, Giulio; Saracco, Giorgio Maria; Pellicano, Rinaldo; Astegiano, Marco | |
| Adalimumab versus azathioprine to halt the progression of bowel damage in Crohn’s disease: application of Lémann Index | 2019 | Ribaldone D.G.; Caviglia G.P.; Pellicano R.; Vernero M.; Italia A.; Morino M.; Saracco G.M.; Astegiano M. | |
| Alpha1-antitrypsin deficiency: What's new after European Respiratory Society Statement | 2018 | Patrucco F.; Venezia L.; Gavelli F.; Pellicano R.; Solidoro P. | |
| AMOXYCILLIN AND METRONIDAZOLE THERAPY FOR HELICOBACTER PYLORI ERADICATION: A 10-YEAR TREND IN TURIN, ITALY | 2017 | Ribaldone, davide giuseppe; Astegiano, Marco; Saracco, Giorgio; Pellicano, Rinaldo | |
| Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory bowel disease | 2008 | Simondi D.; Mengozzi G.; Betteto S.; Bonardi R.; Ghignone R.P.; Fagoonee S.; Pellicano R.; Sguazzini C.; Pagni R.; Rizzetto M.; Astegiano M. | |
| Apparent diffusion coefficient and enhancement patterns in MR imaging as markers of severe or moderate ileum inflammation in Crohn's disease | 2019 | Faletti, R; Ribaldone, DG; Gatti, M; Perazzini, C; Robella, M; Angelino, F; Saracco, GM; Astegiano, M; Pellicano, R; Fonio, P | |
| Asthma and gastroesophageal reflux disease: A multidisciplinary point of view | 2017 | Solidoro P.; Patrucco F.; Fagoonee S.; Pellicano R. | |
| Autoimmune Hepatitis and Fibrosis | 2023 | Pellicano, Rinaldo; Ferro, Arianna; Cicerchia, Francesca; Mattivi, Simone; Fagoonee, Sharmila; Durazzo, Marilena | |
| Bariatric Surgery and Inflammatory Bowel Disease: a Role for Microbiota? | 2020 | Ribaldone D.G.; Pellicano R. | |
| Benefit of supplements in functional dyspepsia after treatment of Helicobacter pylori | 2014 | Pellicano, R; Ribaldone, D.G.; Saracco, G.M.; Leone, N.; De Angelis, C.; Arrigoni, A.; Morello, E.; Sapone, N.; Cisarò, F.; Astegiano, M. | |
| Causes of childhood epilepsy: a look for celiac disease? | 2021 | RIBALDONE, Davide G.; PELLICANO, Rinaldo |